Certain disturbances in asprosin secretion may occur in individuals with metabolic syndrome, type 2 diabetes, or obesity; it has been shown that asprosin levels are significantly elevated in these individuals [3]. This evidence concerns the gene FBN1 and type 2 diabetes mellitus.